The transcriptional co-activators yes-associated protein (YAP) was considered as oncogene in many types of cancer; ITGA2 stimulating YAP activity was associated with unfavorable survival of pancreatic cancer patients [45]. This evidence concerns the gene ITGA2 and pancreatic neoplasm.